Quanterix Corp.

Quanterix Corp.

Quanterix Corp.

Overview
Date Founded

2007

Headquarters

113 Hartwell Avenue,Lexington, MA 02421

Type of Company

Public

Employees (Worldwide)

248

Industries

Pharmaceuticals
Market & Policy Research
IT Consulting & Services
Medical Support Services
Biotechnology
Medical Products & Equipment
Retail: Drug Stores

Company Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Contact Data
Trying to get in touch with decision makers at Quanterix Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President, Chairman & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer

General Counsel & Secretary

General Counsel

Senior Vice President, Research & Development & Chief Technology Officer

Vice President & General Manager of Applications & Reagents

Senior Director, Engineering

Director of Communications & Marketing

Board of Directors

President, Chairman & Chief Executive Officer at Quanterix Corp.

Co-Founder at ARCH Venture Partners

Co-Founder at Quanterix Corp.

Chief Operations Officer at Sherlock Biosciences, Inc.

Senior Vice President, General Counsel & Corporate Secretary at Itron, Inc.

Co-Founder at Perspecta Trust LLC

Founder & Chairman at Novalis LifeSciences

Vice President-Business Development at bioMerieux, Inc.

Paths to Quanterix Corp.
Potential Connections via
Relationship Science
You
Quanterix Corp.
Owners & Shareholders
Details Hidden

Our firm was founded to help small investors build significant capital over time. Since we believe in owning as many promising stocks as possible, we generally buy on margin.* Borrowing to invest can force liquidations if the market collapses, so we try to balance this exposure by selling short. This ability to seek investments both up and downstream is rarely available to smaller investors. We, however, view it as an effective tool that doubles our clients' dollars at work (it also doubles our commissions), while moderately reducing their exposure to abrupt swings in the market. Our approach is not for the short-term investor. Clients must be able and willing to accept risks. Accounts will experience sharp fluctuations month to month, year to year. It takes a strong stomach to invest with us. Clients entrust decision making for their accounts to us: we buy and sell without asking our clients to authorize in advance each transaction. We are paid commissions for our work

Details Hidden

Frontier manages equity portfolios generally on a fully discretionary basis. They believe that a disciplined and consistent approach to fundamental, bottom-up research leads to superior long-term investment performance. The firm invests in stocks with prospects for improving businesses with long-term unrecognized earnings power that are selling at attractive valuations.

Details Hidden

GIM is an active manager that employs fundamental bottom-up research to invest in stocks of companies that they believe exhibit a critical combination of superior growth prospects and attractive stock valuations. The firm specializes in small/micro-cap equity securities.

Recent Transactions
Details Hidden

Quanterix Corp. issued USD Common Stock

Details Hidden

Quanterix Corp. issued . USD Common Stock

Details Hidden

Quanterix Corp. purchases UmanDiagnostics AB

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Underwriter

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Professional

Advised onQuanterix Corp. issued USD Common Stock

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

DuPont de Nemours, Inc. operates as a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics & Imaging, Nutrition & Biosciences, Transportation & Industrial, Safety & Construction, and Non-Core. The Electronics & Imaging segment provides permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless and electrolytic metallization solutions, as well as patterning solutions and materials and innovative metallization processes for metal finishing, decorative, and industrial applications. The Nutrition & Biosciences segment provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The Transportation & Industrial segment engineering resins, adhesives, silicones, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The Safety & Construction segment provides engineering products and integrated systems for a number of industries including, worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The Non-Core segment supplier of key materials for the manufacturing of photovoltaic cells and panels, including SOLAMET metallization pastes, TEDLAR backsheet materials, and FORTASUN silicone encapsulants and adhesives. The company was founded in 1897 and is headquartered in Wilmington, DE.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Key Stats and Financials As of 2019
Market Capitalization
$2.86B
Total Enterprise Value
$491M
Earnings Per Share
$-1.63
Revenue
$56.7M
Net Profit
$-40.8M
EBITDA
$-36.7M
EBITDAMargin
-64.67%
Total Debt
$7.66M
Total Equity
$129M
Enterprise Value / Sales
8.66x
TEVNet Income
-12.05x
Debt TEV
0.02x
Three Year Compounded Annual Growth Rate Of Revenue
47.76%
Investors
Details Hidden

Former Executive Chairman at True Materials, Inc.

Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides financing for early stage capital requirements.

Details Hidden

Bain Capital Ventures seeks investment opportunities in companies located in the US. The firm focuses on companies operating in the fields of infrastructure software, SaaS, data services, marketing tech, finTech, consumer and healthcare with an investment size ranging from $1 million to $100 million. It provides financing for seed to growth stage capital requirements.

Suppliers
Stratec SE Industrial Machinery & Manufacturing | Birkenfeld, Germany

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Tufts University Schools & Student Services

Tufts University is a private research university located in Medford/Somerville, near Boston, in the U.S. state of Massachusetts. The university is organized into ten schools, including two undergraduate programs and eight graduate divisions, on four campuses in Massachusetts and the French Alps. The university emphasizes active citizenship and public service in all of its disciplines and is known for its internationalism and study abroad programs.

Paramit Holding Co. LLC Holding Companies | New York, NY

Paramit Holding Co. LLC operates as a holding company. It offers electro medical products. The company is headquartered in New York, NY.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Quanterix Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Quanterix Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Quanterix Corp..